Tuesday, October 25, 2005

Sexual health & women (Herpes)


Sexual health & women
The Appalachian Online - Oct 20 11:41 AM
There are many ways to be sexually healthy in Boone: just know what organizations are there to help. The prevalence of sexually transmitted diseases and unexpected pregnancies make sexual health knowledge a top priority.Save to My Web

Commercial Insight: Herpes and Respiratory Antivirals - Leaders Rise and Fall
Pharmaceutical Business Review - Oct 19 6:27 PM
Introduction Within the herpes and respiratory antiviral subcategory HSV/VZV products have been key growth drivers, accounting for 77% of a market worth $2,190m in 2004. Despite lost of US branded Valtrex in 2009, the continued uptake of flu and post-transplant CMV antivirals along with the anticipated launch of first-in-class RSV antiviral, A-60444 will to some extent offset revenue loss by 2014.Save to My Web

Prairie Spy
New York Mills Herald - Oct 20 9:30 AM
They're all grown up and gone now, but The Young Girls-my daughters-will always be teenagers. That's what I remember them as the most. Diaper stage-who wants to remember that? Terrible twos, same thing. Nope. Teenagers are the most memorable.Save to My Web

Depomed Completes Enrollment for Phase II Clinical Trial for Gabapentin GR(TM)
[Press Release] Business Wire via Yahoo! Finance - Oct 24 5:00 AM
Depomed, Inc. today announced that it has completed enrollment for the Phase II clinical trial evaluating the safety and efficacy of its Gabapentin extended release tablets to treat patients with postherpetic neuralgia, a long-lasting pain condition associated with nerve damage from herpes zoster, or shingles, infection.Save to My Web

Depomed Completes Enrollment for Phase II Clinical Trial for Gabapentin GR(TM)
RedNova - Oct 24 9:10 AM
Depomed, Inc.Save to My Web

NPS Pharmaceuticals to Promote Allergan's RESTASIS(R) to Rheumatologists in the United States
[Press Release] PR Newswire via Yahoo! Finance - Oct 24 6:00 AM
NPS Pharmaceuticals, Inc. announced today that it has executed an agreement with Allergan, Inc. to promote RESTASIS , the first and currently only prescription eye drop to increase tear production in patients with chronic dry eye disease , a common condition characterized by insufficient tear production to lubricate the eye.Save to My Web

Herpes